---
title: "Bell Potter Remains a Buy on Oneview Healthcare Chess Depository Interests repr 1 (ONVVF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284280994.md"
description: "Bell Potter analyst Martyn Jacobs has maintained a Buy rating on Oneview Healthcare Chess Depository Interests repr 1 (ONVVF) with a price target of A$0.45. Despite Jacobs' average return of -19.8% and a 16.39% success rate, the overall analyst consensus suggests a Moderate Buy rating for the stock, also targeting A$0.45."
datetime: "2026-04-27T23:38:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284280994.md)
  - [en](https://longbridge.com/en/news/284280994.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284280994.md)
generator: "portal-rs"
---

# Bell Potter Remains a Buy on Oneview Healthcare Chess Depository Interests repr 1 (ONVVF)

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Oneview Healthcare Chess Depository Interests repr 1 today and set a price target of A$0.45.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Jacobs is an analyst with an average return of -19.8% and a 16.39% success rate. Jacobs covers the Healthcare sector, focusing on stocks such as EMvision Medical Devices Ltd., Medical Developments International Limited, and EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Oneview Healthcare Chess Depository Interests repr 1 with a A$0.45 average price target.

### Related Stocks

- [ONE.AU](https://longbridge.com/en/quote/ONE.AU.md)
- [IXJ.AU](https://longbridge.com/en/quote/IXJ.AU.md)
- [EMV.AU](https://longbridge.com/en/quote/EMV.AU.md)
- [MVP.AU](https://longbridge.com/en/quote/MVP.AU.md)

## Related News & Research

- [Qoria (FMZNF) Gets a Buy from Canaccord Genuity](https://longbridge.com/en/news/284127081.md)
- [ONE: Recurring revenue up 13% and gross margin at 70%, with new US growth from Bedside Hub launch](https://longbridge.com/en/news/297097326.md)
- [Skinkandy Limited (SK1) was downgraded to a Hold Rating at Ord Minnett](https://longbridge.com/en/news/298863432.md)
- [Ord Minnett Remains a Buy on Select Harvests (SHVTF)](https://longbridge.com/en/news/298396403.md)
- [Analyst Reiterates Buy on Tuas Ltd., Keeps A$5 Price Target Amid Strong Fundamentals and Upside Potential](https://longbridge.com/en/news/298929340.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**